Reach Banner
Last name



This is a "connection" page, showing publications co-authored by Sylvain Baruchel and Eric Bouffet.

Connection Strength
  1. Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, Hukin J, Bartels U, Foreman N, Kellie S, Hilden J, Etzl M, Wilson B, Stephens D, Tabori U, Baruchel S. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol. 2012 Apr 20; 30(12):1358-63.
    View in: PubMed
    Score: 0.552
  2. Baruchel S, Sharp JR, Bartels U, Hukin J, Odame I, Portwine C, Strother D, Fryer C, Halton J, Egorin MJ, Reis RM, Martinho O, Stempak D, Hawkins C, Gammon J, Bouffet E. A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours. Eur J Cancer. 2009 Sep; 45(13):2352-9.
    View in: PubMed
    Score: 0.456
  3. Baruchel S, Diezi M, Hargrave D, Stempak D, Gammon J, Moghrabi A, Coppes MJ, Fernandez CV, Bouffet E. Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours. Eur J Cancer. 2006 Sep; 42(14):2335-42.
    View in: PubMed
    Score: 0.375
  4. Bartels U, Wolff J, Gore L, Dunkel I, Gilheeney S, Allen J, Goldman S, Yalon M, Packer RJ, Korones DN, Smith A, Cohen K, Kuttesch J, Strother D, Baruchel S, Gammon J, Kowalski M, Bouffet E. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol. 2014 Nov; 16(11):1554-9.
    View in: PubMed
    Score: 0.161
  5. Bartels U, Baruchel S, Carret AS, Crooks B, Hukin J, Johnston D, Silva M, Strother D, Wilson B, Zelcer S, Eisenstat D, Sung L, Bouffet E. The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour Consortium. Curr Oncol. 2011 Jan; 18(1):e19-24.
    View in: PubMed
    Score: 0.127
  6. Sharp JR, Bouffet E, Stempak D, Gammon J, Stephens D, Johnston DL, Eisenstat D, Hukin J, Samson Y, Bartels U, Tabori U, Huang A, Baruchel S. A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. Eur J Cancer. 2010 Dec; 46(18):3271-9.
    View in: PubMed
    Score: 0.123
  7. Hargrave D, Bouffet E, Gammon J, Becker L, Rutka J, Baruchel S. Response to low dose temozolomide in radiation induced gliomatosis cerebri. Med Pediatr Oncol. 2003 Dec; 41(6):562-4.
    View in: PubMed
    Score: 0.078
  8. Hargrave DR, Bouffet E, Gammon J, Tariq N, Grant RM, Baruchel S. Phase I study of fotemustine in pediatric patients with refractory brain tumors. Cancer. 2002 Sep 15; 95(6):1294-301.
    View in: PubMed
    Score: 0.072
  9. Deyell RJ, Wu B, Rassekh SR, Tu D, Samson Y, Fleming A, Bouffet E, Sun X, Powers J, Seymour L, Baruchel S, Morgenstern DA. Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218. Pediatr Blood Cancer. 2019 03; 66(3):e27540.
    View in: PubMed
    Score: 0.055
  10. Tomlinson D, Bartels U, Gammon J, Hinds PS, Volpe J, Bouffet E, Regier DA, Baruchel S, Greenberg M, Barrera M, Llewellyn-Thomas H, Sung L. Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals. CMAJ. 2011 Nov 22; 183(17):E1252-8.
    View in: PubMed
    Score: 0.034
  11. Tomlinson D, Capra M, Gammon J, Volpe J, Barrera M, Hinds PS, Bouffet E, Geenberg ML, Baruchel S, Llewellyn-Thomas HA, Sung L. Parental decision making in pediatric cancer end-of-life care: using focus group methodology as a prephase to seek participant design input. Eur J Oncol Nurs. 2006 Jul; 10(3):198-206.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.